Kimia Biosciences Ltd Share Price & Stock Analysis

Kimia Biosciences Ltd (BSE: 530313) is a New Delhi, Delhi-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹151 Cr, it ranks #2,886 by market cap among the 6,197 Indian listed companies on FinBizNet, and #59 of 86 in Medicinal Chemicals and Botanical Products. At ₹32.50 (as of 16 Nov 2026), the share price is 24.9% below its 52-week high of ₹43.28 and 40.1% above its 52-week low of ₹23.20. The share price is up 4.6% over one year and up 12.9% over three months.

Key Metrics

Current Price₹32.50
Market Cap₹151 Cr
BSE Code530313
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio20.4
Return on Equity53.70%
Return on Assets7.26%
52-Week Range₹23.20 – ₹43.28
1-Year Price Change+4.6%
3-Month Price Change+12.9%
Beta (1Y)1.44
HeadquartersNew Delhi, Delhi
Websitewww.kimiabiosciences.com

Shareholding and Delivery

Delivery averaged 90.8% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Kimia Biosciences Ltd

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. The company was incorporated in 1993 and is based in New Delhi, India.

Products and Services

1. Pharmaceuticals-This segment provides contract manufacturing services for latest (R&D based) and generic (regular) bulk drug intermediates for pharmaceutical companies in India.

Business Segments

1. Pharmaceuticals-100%

Kimia Biosciences Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Kimia Biosciences Ltd₹151 Cr20.453.70%—+4.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Kimia Biosciences Ltd?

Kimia Biosciences Ltd is trading at ₹32.50, with a market capitalisation of ₹151 Cr.

Which sector does Kimia Biosciences Ltd belong to?

Kimia Biosciences Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Kimia Biosciences Ltd?

Kimia Biosciences Ltd has a P/E of 20.4 and a return on equity of 53.70%.

What is the stock symbol of Kimia Biosciences Ltd?

Kimia Biosciences Ltd is listed on the BSE under the scrip code 530313.

How has Kimia Biosciences Ltd's share price moved over the past year?

Kimia Biosciences Ltd's share price is up 4.6% over one year and up 12.9% over three months. Its 52-week range is ₹23.20 to ₹43.28.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.